{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T08:26:24Z","timestamp":1794212784281,"version":"4.8.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81860765"],"award-info":[{"award-number":["81860765"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ijbiomac.2025.147252","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T17:12:27Z","timestamp":1757092347000},"page":"147252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P1","title":["Dual-function fab-scFv fusion antibody ameliorates ulcerative colitis by targeting hFcRn-mediated colonic enrichment and TNF-\u03b1 neutralization"],"prefix":"10.1016","volume":"328","author":[{"given":"Miao","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guorong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zishao","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Kesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinliang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ijbiomac.2025.147252_bb0005","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","article-title":"The global burden of IBD: from 2015 to 2025","volume":"12","author":"Kaplan","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.147252_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103708","article-title":"Burden of inflammatory bowel disease among elderly, 1990\u20132019: a systematic analysis based on the global burden of disease study 2019","volume":"24","author":"Chen","year":"2024","journal-title":"Autoimmun. Rev."},{"issue":"10080","key":"10.1016\/j.ijbiomac.2025.147252_bb0015","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.147252_bb0020","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41577-022-00792-3","article-title":"Death by TNF: a road to inflammation","volume":"23","author":"van Loo","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.147252_bb0025","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.immuni.2019.03.017","article-title":"Cytokine networks in the pathophysiology of inflammatory bowel disease","volume":"50","author":"Friedrich","year":"2019","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.147252_bb0030","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1136\/gutjnl-2019-320022","article-title":"25 years of anti-TNF treatment for inflammatory bowel disease: lessons from the past and a look to the future","volume":"70","author":"D'Haens","year":"2021","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.147252_bb0035","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrd4363","article-title":"Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies","volume":"13","author":"Mitragotri","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.147252_bb0040","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/cpt.1609","article-title":"Achieving mucosal healing in inflammatory bowel diseases: which drug concentrations need to be targeted?","volume":"106","author":"Van den Berghe","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.147252_bb0045","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjaf063","article-title":"Drug tissue concentration and STAT3 modulation as determinants of tofacitinib response in ulcerative colitis","volume":"19","author":"Verstockt","year":"2025","journal-title":"J. Crohns Colitis"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.147252_bb0050","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41577-022-00821-1","article-title":"The therapeutic age of the neonatal Fc receptor","volume":"23","author":"Pyzik","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"01","key":"10.1016\/j.ijbiomac.2025.147252_bb0055","article-title":"Recent advances in neonatal Fc receptor targeted drug delivery systems","volume":"57","author":"He","year":"2022","journal-title":"Acta Pharm. Sin."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.147252_bb0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/07388551.2013.834293","article-title":"Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics","volume":"35","author":"Rath","year":"2015","journal-title":"Crit. Rev. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.147252_bb0065","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.addr.2015.02.005","article-title":"The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy","volume":"91","author":"Sockolosky","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.147252_bb0070","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1038\/mt.2014.150","article-title":"Therapeutic tissue regeneration by a macrophage colony-stimulating factor Fc conjugate","volume":"22","author":"van den Boorn","year":"2014","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.147252_bb0075","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.143958","article-title":"Enhancing durability of CIS43 monoclonal antibody by Fc mutation or AAV delivery for malaria prevention","volume":"6","author":"Kisalu","year":"2021","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147252_bb0080","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/s41467-024-46025-0","article-title":"Targeted delivery of Fc-fused PD-L1 for effective management of acute and chronic colitis","volume":"15","author":"Tang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2025.147252_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106259","article-title":"Functionalized FcRn-targeted nanosystems for oral drug delivery: a new approach to colorectal cancer treatment","volume":"176","author":"Hameedat","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2025.147252_bb0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jconrel.2016.03.017","article-title":"Single chain antibody fragments with pH dependent binding to FcRn enabled prolonged circulation of therapeutic peptide in vivo","volume":"229","author":"Qiu","year":"2016","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.147252_bb0095","first-page":"752","article-title":"Oral uptake and persistence of the FnAb-8 protein characterized by in situ radio-labeling and PET\/CT imaging","volume":"15","author":"Wang","year":"2020","journal-title":"Asian J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.147252_bb0100","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s44321-024-00026-0","article-title":"Inhibition of SFTSV replication in humanized mice by a subcutaneously administered anti-PD1 nanobody","volume":"16","author":"Ji","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.147252_bb0105","doi-asserted-by":"crossref","first-page":"32747","DOI":"10.1038\/srep32747","article-title":"Therapeutic TNF inhibitors can differentially stabilize trimeric TNF by inhibiting monomer exchange","volume":"6","author":"van Schie","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.147252_bb0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jconrel.2020.03.004","article-title":"FcRn overexpression in human cancer drives albumin recycling and cell growth; a mechanistic basis for exploitation in targeted albumin-drug designs","volume":"322","author":"Larsen","year":"2020","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.147252_bb0115","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41577-024-01008-6","article-title":"Strategies for targeting cytokines in inflammatory bowel disease","volume":"24","author":"Neurath","year":"2024","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.147252_bb0120","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41590-019-0415-0","article-title":"Targeting immune cell circuits and trafficking in inflammatory bowel disease","volume":"20","author":"Neurath","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.147252_bb0125","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jconrel.2024.08.023","article-title":"An in situ bioadhesive foam as a large intestinal delivery platform for antibody fragment to treat inflammatory bowel disease","volume":"374","author":"Zhang","year":"2024","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.147252_bb0130","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.drudis.2018.06.003","article-title":"Therapeutic application of antibody fragments in autoimmune diseases: current state and prospects","volume":"23","author":"Fernandes","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijbiomac.2025.147252_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.01927","article-title":"Solubility, stability, and avidity of recombinant antibody fragments expressed in microorganisms","volume":"11","author":"Kang","year":"2020","journal-title":"Front. Microbiol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.147252_bb0140","article-title":"Cell surface dynamics and cellular distribution of endogenous FcRn","volume":"12","author":"D'Hooghe","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.147252_bb0145","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.4049\/jimmunol.179.5.2999","article-title":"NF-kappaB signaling regulates functional expression of the MHC class I-related neonatal Fc receptor for IgG via intronic binding sequences","volume":"179","author":"Liu","year":"2007","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.147252_bb0150","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.nano.2015.02.018","article-title":"Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue","volume":"11","author":"Hua","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2025.147252_bb0155","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.addr.2018.06.021","article-title":"Bioresponsive drug delivery systems in intestinal inflammation: state-of-the-art and future perspectives","volume":"146","author":"Kotla","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.147252_bb0160","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3109\/00498254.2014.941963","article-title":"Application of human FcRn transgenic mice as a pharmacokinetic screening tool of monoclonal antibody","volume":"44","author":"Haraya","year":"2014","journal-title":"Xenobiotica"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.147252_bb0165","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s11095-021-03028-6","article-title":"Combination of cassette-dosing and microsampling for reduced animal usage for antibody pharmacokinetics in cynomolgus monkeys, wild-type mice, and human FcRn transgenic mice","volume":"38","author":"Nagayasu","year":"2021","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147252_bb0170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.autrev.2013.06.004","article-title":"Innate and adaptive immunity in inflammatory bowel disease","volume":"13","author":"Geremia","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.147252_bb0175","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1007\/s10620-011-1780-1","article-title":"Th1 responses are more susceptible to infliximab-mediated immunosuppression than Th17 responses","volume":"56","author":"Kanayama","year":"2011","journal-title":"Dig. Dis. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.147252_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17020225","article-title":"Association between genetic polymorphisms and response to anti-TNFs in patients with inflammatory bowel disease","volume":"17","author":"Prieto-Perez","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.147252_bb0185","doi-asserted-by":"crossref","first-page":"32154","DOI":"10.1038\/srep32154","article-title":"TGEV infection up-regulates FcRn expression via activation of NF-kappaB signaling","volume":"6","author":"Guo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.147252_bb0190","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.cytogfr.2022.07.005","article-title":"The involvement of TH17 cells in the pathogenesis of IBD","volume":"69","author":"Jiang","year":"2023","journal-title":"Cytokine Growth Factor Rev."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.147252_bb0195","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41575-023-00769-0","article-title":"Macrophages in intestinal homeostasis and inflammatory bowel disease","volume":"20","author":"Hegarty","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.147252_bb0200","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/ecco-jcc\/jjw053","article-title":"Mechanism of action of anti-TNF therapy in inflammatory bowel disease","volume":"10","author":"Levin","year":"2016","journal-title":"J. Crohns Colitis"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.147252_bb0205","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/rheumatology\/keq031","article-title":"Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents","volume":"49","author":"Horiuchi","year":"2010","journal-title":"Rheumatology (Oxford)"}],"updated-by":[{"DOI":"10.1016\/j.ijbiomac.2026.155198","type":"expression_of_concern","label":"Expression of concern","source":"publisher","updated":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T00:00:00Z","timestamp":1794182400000}}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025078092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025078092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T22:06:55Z","timestamp":1772834815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025078092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":41,"alternative-id":["S0141813025078092"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.147252","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual-function fab-scFv fusion antibody ameliorates ulcerative colitis by targeting hFcRn-mediated colonic enrichment and TNF-\u03b1 neutralization","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.147252","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"147252"}}